Can JAK Inhibitors Save Lives From COVID-19? Pfizer Might Let RECOVERY Answer The Question

Promising Signs From Phase II Study

 
• By Andrew McConaghie
Sao Paulo Street
The STOP-COVID study of tofacitinib was conducted in Sao Paulo, Brazil. • Source: Alamy

More from Business

More from Scrip